Assessment and Localisation of Response to Primary Systemic Therapy in Breast Cancer

被引：1
|
作者：
Noble, Frith [1 ]
机构：
[1] Wishaw Gen Hosp, Radiol Dept, 50 Netherton St, Wishaw ML2 0DP, Scotland
来源：
ULTRASOUND | 2009年 / 17卷 / 02期
关键词：
Primary Systemic Therapy; Ultrasound Guided Marking;
D O I：
10.1179/174313409X415819
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Primary systemic therapy (PST) is used in non-metastatic breast cancer to decrease tumour size and reduce the extent of surgery. This article reviews imaging and surgical issues associated with the increasing use of PST in the management of breast cancer. The role of imaging, with a special focus on ultrasound, is evaluated.
引用
收藏
页码：80 / 84
页数：5
相关论文
共 50 条
  • [21] Primary and adjuvant systemic therapy for operable breast cancer
    Thomssen, C.
    Huober, J.
    ONKOLOGE, 2008, 14 (05): : 504 - 513
  • [22] Primary systemic therapy for advanced inoperable breast cancer
    Palmisano, V.
    Leonardi, V.
    Pepe, A.
    Usset, A.
    Arcuri, C.
    Laudani, A.
    Savio, G.
    Rondello, G.
    Giresi, A.
    Amari, P.
    Agostara, B.
    ANNALS OF ONCOLOGY, 2007, 18 : 49 - 49
  • [23] Genetic polymorphisms as predictors of therapy response in a trial of neoadjuvant systemic therapy for primary invasive breast cancer
    Marme, F.
    Hahn, M.
    Lichter, P.
    Rom, J.
    Mansouri, K.
    Bauknecht, T.
    Sinn, H. -P.
    Sohn, C.
    Schneeweiss, A.
    ONKOLOGIE, 2008, 31 : 49 - 49
  • [24] Assessment of Pathological Complete Response in Patients with Breast Cancer Receiving Neoadjuvant Systemic Therapy
    Farrukh, Nida
    Bano, Razia
    Naqvi, Syeda Rifaat Qamar
    Latif, Humera
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (06): : 746 - 750
  • [25] Assessment of response in primary chemotherapy for breast cancer
    Colleoni, M
    Orlando, L
    Robertson, C
    Nole, F
    Peruzzotti, G
    Cassano, R
    Orvieto, E
    Viale, G
    Goldhirsch, A
    ANNALS OF ONCOLOGY, 1998, 9 (10) : 1140 - 1141
  • [26] Metaplastic breast cancer: Prognosis and response to systemic therapy
    Rayson, D
    Adjei, AA
    Suman, VJ
    Wold, LE
    Ingle, JN
    ANNALS OF ONCOLOGY, 1999, 10 (04) : 413 - 419
  • [27] Omitting surgery for early breast cancer showing clinical complete response to primary systemic therapy
    Shigematsu, Hideo
    Fujisawa, Tomomi
    Shien, Tadahiko
    Iwata, Hiroji
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (06) : 629 - 634
  • [28] Impact of trastuzumab on the pathological complete response (pCR) rates in primary systemic therapy for breast cancer
    Mizuta, N.
    Nakajima, H.
    Sakaguchi, K.
    Hachimine, Y.
    Fujiwara, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [29] FDG-PET-CT in the early response evaluation for primary systemic therapy of breast cancer
    Tokes, Timea
    Torgyik, Laszlo
    Kulka, Janina
    Borka, Katalin
    Szasz, Attila Marcell
    Toth, Andrea
    Harsanyi, Laszlo
    Lengyel, Zsolt
    Gyoerke, Tamas
    Dank, Magdolna
    CENTRAL EUROPEAN JOURNAL OF MEDICINE, 2014, 9 (02): : 306 - 312
  • [30] ASSESSMENT OF RESPONSE TO THERAPY OF PRIMARY BREAST-CANCER BY MAMMOGRAPHY AND PHYSICAL-EXAMINATION
    DERSHAW, DD
    DROSSMAN, S
    LIBERMAN, L
    ABRAMSON, A
    CANCER, 1995, 75 (08) : 2093 - 2098
12345